Pier 88 Investment Partners LLC Rocket Pharmaceuticals, Inc. Transaction History
Pier 88 Investment Partners LLC
- $75.6 Million
- Q4 2024
A detailed history of Pier 88 Investment Partners LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 37,500 shares of RCKT stock, worth $313,125. This represents 0.62% of its overall portfolio holdings.
Number of Shares
37,500
Previous 32,490
15.42%
Holding current value
$313,125
Previous $600,000
21.5%
% of portfolio
0.62%
Previous 0.79%
Shares
4 transactions
Others Institutions Holding RCKT
# of Institutions
244Shares Held
108MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$148 Million3.63% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$117 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$54.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$51.7 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$43.4 Million1.26% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $632M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...